Australia markets open in 7 hours 9 minutes

VYNE Therapeutics Inc. (VYNE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.7301+0.0301 (+1.11%)
As of 12:39PM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
30,620
30,908
42,250
57,563
-
Other short-term investments
62,633
0
0
1,027
-
Total cash
93,253
30,908
42,250
58,590
-
Net receivables
-
173
7,583
15,819
-
Inventory
-
-
7,291
7,404
-
Other current assets
2,656
2,300
4,903
4,591
-
Total current assets
95,963
38,275
63,186
87,259
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
207
0
905
2,581
-
Accumulated depreciation
-
0
-551
-443
-
Net property, plant and equipment
207
0
354
2,138
-
Other long-term assets
1,515
2,483
3,506
4,345
-
Total non-current assets
1,722
2,483
3,860
6,483
-
Total assets
97,685
40,758
67,046
93,742
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
1,659
2,386
6,510
4,780
-
Accrued liabilities
4,119
4,381
8,593
11,452
-
Other current liabilities
-
-
-
104
485
Total current liabilities
7,538
9,345
18,410
21,765
-
Non-current liabilities
Long-term debt
-
-
-
33,174
-
Other long-term liabilities
1,313
-
-
457
-
Total non-current liabilities
1,412
211
0
34,484
-
Total liabilities
8,950
9,556
18,410
56,249
-
Stockholders' equity
Common stock
1
0
5
4
-
Retained earnings
-691,336
-662,735
-639,525
-566,196
-
Accumulated other comprehensive income
26
0
0
0
-
Total stockholders' equity
88,735
31,202
48,636
37,493
-
Total liabilities and stockholders' equity
97,685
40,758
67,046
93,742
-